1Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity[J]. Annu Rev Immunol, 2000, 18:621-663.
2Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-kappaB [ J ]. Nat Rev lmmunol, 2005,5 ( 6 ) : 435 -445.
3Siebenlist U, Franzoso G,Brown K. Structure, regulation and function of NF-kappa B[J]. Annu Rev Cell Biol, 1994,10:405-455.
4Carrasco D, Ryseck RP, Bravo R. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells [ J ]. Development, 1993,118 ( 4 ) : 1221 -1231.
5Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle[ J]. Cell, 2002,109 Suppl: S81-96.
6Moorthy AK, Ghosh G. p105. Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B[ J]. J Biol Chem, 2003,278( 1 ) :556-566.
7Baeuerte PA, Baichwal VR. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules [ J ]. Adv Immunol, 1997,65:111-137.
8Yamazaki S, Muta T,Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei [ J ]. J Biol Chem, 2001,276 (29) :27657-27662.
9Fan C,Li Q,Zhang Y,et al. IkappaBalpha and IkappaBbeta possess injury context-speciflc functions that uniquely influence hepatic NF- kappaB induction and inflammation [ J ]. J Clin Invest, 2004,113 (5) :746-755.
10Kitamura H, Kanehira K,Okita K, et al. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production [ J ]. FEBS Lett, 2000,485 (1) :53-56.
